Mechanisms of retinal ganglion cell injury and defense in glaucoma.
Glaucoma is a disease in which retinal ganglion cells (RGCs) die leading ultimately to blindness. Over the past decade and a half, information has begun to emerge regarding specific molecular responses of the retina to conditions of elevated intraocular pressure (IOP). It is now clear that the state of the RGC in glaucoma depends on a balance of pro-survival and pro-death pathways in the retina and details of these responses are still being worked out. In this review, we will discuss the evidence supporting the involvement of specific apoptotic cascades as well as the insults that trigger RGC apoptosis. In addition, we will present evidence supporting the existence of endogenous protective mechanisms as well as exogenous neuroprotective strategies.
Qu
Juan
J
Department of Ophthalmology, Howe Laboratory of Ophthalmology, Massachusetts Eye & Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA.
Wang
Danyi
D
Grosskreutz
Cynthia L
CL
D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins / Q000502:physiology; D019703:Calcineurin / Q000502:physiology; D002154:Calpain / Q000502:physiology; D020169:Caspases / Q000502:physiology; D002470:Cell Survival / Q000502:physiology; D019610:Cytoprotection; D005901:Glaucoma / Q000473:pathology*; D006801:Humans; D012165:Retinal Ganglion Cells / Q000473:pathology*
D051017:Apoptosis Regulatory Proteins; D019703:Calcineurin; D002154:Calpain; D020169:Caspases
Invest Ophthalmol Vis Sci. 2000 Mar;41(3):764-74
10711692
N Engl J Med. 2009 Mar 12;360(11):1113-24
19279343
Invest Ophthalmol Vis Sci. 2004 Apr;45(4):1247-58
15037594
J Neurosci Res. 2006 May 15;83(7):1342-51
16528750
Biochimie. 2002 Feb-Mar;84(2-3):223-31
12022953
Eur J Neurosci. 1996 Aug;8(8):1735-45
8921264
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2456-63
18263808
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3049-54
20107181
Arch Ophthalmol. 1996 Mar;114(3):299-305
8600890
Am J Pathol. 2005 Sep;167(3):673-81
16127148
J Glaucoma. 2007 May;16(3):334-43
17438430
Neuroscience. 2006 Sep 15;141(4):2139-45
16843603
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13469-74
19805021
Exp Eye Res. 2005 May;80(5):663-70
15862173
Science. 1999 Apr 9;284(5412):339-43
10195903
Brain Res. 2006 Nov 29;1122(1):209-21
17045251
Physiol Rev. 2003 Jul;83(3):731-801
12843408
Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1787-94
11431443
Invest Ophthalmol Vis Sci. 2009 Feb;50(2):717-28
18952924
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2932-42
16799036
PLoS Genet. 2005 Jul;1(1):17-26
16103918
Prog Retin Eye Res. 2006 Sep;25(5):490-513
16962364
Eur J Neurosci. 1998 Aug;10(8):2751-6
9767407
J Biol Chem. 2004 Feb 6;279(6):4929-40
14627704
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12242-7
16103353
Brain Res. 2005 Sep 28;1057(1-2):17-28
16139821
Mol Cell Biochem. 2007 Jul;301(1-2):155-63
17242991
J Neurosci. 1994 Jul;14(7):4368-74
8027784
Invest Ophthalmol Vis Sci. 2003 May;44(5):1982-92
12714633
FEBS J. 2005 Nov;272(21):5436-53
16262685
Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2640-51
15277487
Prog Retin Eye Res. 2005 Mar;24(2):217-40
15610974
Brain Res. 1993 May 21;611(2):272-8
8334520
Arch Ophthalmol. 2004 Sep;122(9):1348-56
15364715
Brain Res Mol Brain Res. 1999 Apr 6;67(1):36-45
10101230
Ageing Res Rev. 2003 Oct;2(4):407-18
14522243
Cell. 1997 Nov 14;91(4):479-89
9390557
Cell Mol Neurobiol. 2008 Feb;28(2):317-29
17554621
Cell. 1998 Aug 21;94(4):481-90
9727491
J Exp Med. 1998 Feb 16;187(4):587-600
9463409
Mol Cell. 1998 Jan;1(2):319-25
9659928
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3978-83
9520478
Vision Res. 1998 May;38(10):1517-24
9667016
Neuroscience. 2006 May 12;139(2):723-32
16458441
Surv Ophthalmol. 2008 Mar-Apr;53(2):150-63
18348880
Arch Ophthalmol. 2000 May;118(5):666-73
10815159
Cell Death Differ. 1999 Nov;6(11):1067-74
10578175
Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1840-7
9286274
J Cell Biol. 1999 Jan 25;144(2):281-92
9922454
Gene Ther. 2006 Sep;13(18):1328-41
16708079
J Biol Chem. 1999 Apr 23;274(17):11549-56
10206961
Vis Neurosci. 2005 Sep-Oct;22(5):637-48
16332275
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4357-65
14507880
J Neurosci. 2006 Dec 6;26(49):12633-41
17151265
J Neurosci Res. 2005 Dec 1;82(5):674-89
16273539
Brain Res Mol Brain Res. 1994 Jul;24(1-4):43-54
7968376
Invest Ophthalmol Vis Sci. 1996 Nov;37(12):2376-81
8933754
J Histochem Cytochem. 2001 Feb;49(2):187-95
11156687
Glia. 2004 Aug 1;47(2):109-19
15185390
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2633-7
12147596
Arch Ophthalmol. 2005 Jan;123(1):64-70
15642814
Invest Ophthalmol Vis Sci. 1999 Apr;40(5):1004-8
10102300
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1522-30
11381056
J Neurosci. 1996 Jul 1;16(13):4186-94
8753880
Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):144-50
11146116
Exp Eye Res. 2007 Aug;85(2):250-8
17586494
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4129-35
17724197
Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5342-8
14638736
J Glaucoma. 2002 Oct;11(5):396-405
12362078
Mol Cell. 1998 Jun;1(7):949-57
9651578
Exp Eye Res. 2000 Aug;71(2):209-13
10930325
Prog Brain Res. 2008;173:423-35
18929125
Trends Cell Biol. 2007 Nov;17(11):519-28
18029183
Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1111-5
10752948
Invest Ophthalmol Vis Sci. 2002 Jan;43(1):15-21
11773007
Exp Eye Res. 2005 May;80(5):681-6
15862175
Exp Eye Res. 1995 Jul;61(1):33-44
7556468
Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1632-6
8127857
Exp Brain Res. 2000 Jun;132(4):476-84
10912828
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2660-7
10509663
Curr Opin Neurobiol. 2008 Jun;18(3):270-5
18778772
Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2545-53
9375574
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):977-85
16505032
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1313-21
15790897
Invest Ophthalmol Vis Sci. 1995 Apr;36(5):774-86
7706025
Graefes Arch Clin Exp Ophthalmol. 1998 Oct;236(10):766-74
9801892
Prog Retin Eye Res. 2005 Nov;24(6):639-62
15953750
J Neurosci Res. 1993 Feb 1;34(2):250-5
8450568
Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2315-23
11527945
Arch Ophthalmol. 2003 Feb;121(2):183-8
12583783
Arch Ophthalmol. 1997 Aug;115(8):1031-5
9258226
Exp Eye Res. 2009 Dec;89(6):921-33
19682984
Invest Ophthalmol Vis Sci. 2001 Apr;42(5):966-74
11274073
J Neurosci. 2000 Dec 1;20(23):8693-700
11102475
Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5420-30
18055788
IUBMB Life. 2008 Sep;60(9):575-90
18478527
Brain Res. 2004 Jun 11;1011(1):99-106
15140649
Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2625-39
15277486
Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1954-64
12037005
Science. 1998 Aug 28;281(5381):1305-8
9721089
Curr Opin Neurobiol. 2005 Feb;15(1):49-57
15721744
Neurosci Lett. 2001 Jun 8;305(2):139-42
11376903
Graefes Arch Clin Exp Ophthalmol. 1985;223(5):250-8
4065591
Invest Ophthalmol Vis Sci. 1996 Mar;37(4):489-500
8595949
Science. 1998 Aug 28;281(5381):1309-12
9721092
Oncogene. 2008 Oct 20;27(48):6245-51
18931691
J Neurobiol. 1994 Apr;25(4):431-8
8077968
Brain Res. 1993 Feb 5;602(2):304-17
8448673
Vision Res. 2002 Jan;42(2):151-7
11809469
Annu Rev Neurosci. 2001;24:677-736
11520916
Oncogene. 1998 Dec 24;17(25):3237-45
9916986
Neurosci Lett. 1995 Jan 2;183(1-2):96-9
7746496
J Biol Chem. 2006 Jun 23;281(25):17321-17336
16603546
Glia. 2000 Apr;30(2):178-86
10719359
AMA Arch Ophthalmol. 1957 Aug;58(2):193-201
13443577
Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1077-87
11923249
Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2884-91
10549648
Prog Brain Res. 2008;173:409-21
18929124
Invest Ophthalmol Vis Sci. 2009 May;50(5):2194-200
19060281
Mol Ther. 2005 Mar;11(3):373-81
15727933
Neurosci Lett. 1990 May 4;112(2-3):179-83
2193255
Exp Eye Res. 2006 Apr;82(4):576-82
16197943
Curr Eye Res. 2005 Nov;30(11):1025-31
16282136
Prog Neurobiol. 2001 Sep;65(1):1-105
11369436
J Neurobiol. 1994 Jan;25(1):92-105
8113786
Mol Cell Neurosci. 2004 May;26(1):63-74
15121179
J Biol Chem. 2001 Dec 7;276(49):46326-32
11574549
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3460-6
11006239
Curr Eye Res. 2002 Dec;25(6):389-95
12789547